IL-1 Signal Inhibition In Alcoholic Hepatitis (ISAIAH): a study protocol for a multicentre, randomised, placebo-controlled trial to explore the potential benefits of canakinumab in the treatment of alcoholic hepatitis.
| Autor: | Vergis, N.1 (AUTHOR) nvergis@ic.ac.uk, Patel, V.2,3,4 (AUTHOR), Bogdanowicz, K.5 (AUTHOR), Czyzewska-Khan, J.5 (AUTHOR), Fiorentino, F.5 (AUTHOR), Day, E.5 (AUTHOR), Cross, M.5 (AUTHOR), Foster, N.1 (AUTHOR), Lord, E.1 (AUTHOR), Goldin, R.1 (AUTHOR), Forrest, E.6 (AUTHOR), Thursz, M.1 (AUTHOR) |
|---|---|
| Zdroj: | Trials. 11/11/2021, Vol. 22 Issue 1, p1-16. 16p. 3 Charts. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|